Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Thermo Fisher Scientific's Olink Platform Selected for World's Largest Human Proteomics Study

January 14, 2025
Thermo Fisher Scientific's Olink platform has been chosen for the world's largest human proteomics study, marking a significant milestone for the company.
The study aims to map the entire human proteome and uncover new insights into human biology and disease. Thermo Fisher's Olink platform, known for its advanced protein analysis capabilities, will play a crucial role in this groundbreaking research. With its high sensitivity and accuracy, the Olink platform will enable researchers to analyze thousands of proteins simultaneously, providing a comprehensive understanding of the complex network of proteins in the human body. Investors are optimistic about the potential impact of this study, with TMO stock showing positive momentum in recent weeks. For a more detailed analysis and forecast of TMO stock, it is recommended to consult professionals at Stocks Prognosis.

Find out how the THERMO FISHER SCIENTIFIC INC. rate is expected to change

Get Forecast for TMO

Investor opinions & comments:

While this study sounds promising, I wonder if it will actually deliver on its goal to map the entire human proteome. It seems like a huge undertaking
— from TylerGonzalez at 01-17-2025 16:53
Investors are right to be optimistic about the potential impact of this study. It could lead to new discoveries and advancements in the field of proteomics
— from MadisonReyes at 01-17-2025 07:12
I'm not convinced that mapping the entire human proteome will provide meaningful insights into human biology and disease. I think there are other areas of research that could be more fruitful
— from RiskyRachel at 01-17-2025 04:32
This study could have significant implications for the medical field. I'm curious to know how it will contribute to our knowledge of human health and potential treatments
— from AnnaDuncan at 01-17-2025 03:28
This is a groundbreaking study that could lead to major advancements in our understanding of human biology and disease. I'm excited to see what new insights will be uncovered
— from CapitalChris at 01-16-2025 08:37
The Olink platform's advanced protein analysis capabilities make it the perfect tool for this study. I can't wait to see the results
— from AndrewRobinson at 01-15-2025 18:00
I'm skeptical about the accuracy and reliability of the Olink platform. Can it really analyze thousands of proteins simultaneously without compromising the results?
— from WealthyWillie at 01-15-2025 14:47
Thermo Fisher Scientific's stock showing positive momentum is a reflection of the confidence investors have in the company and the potential success of this study
— from WealthyWes at 01-15-2025 02:05
This is a significant milestone for Thermo Fisher Scientific. The fact that their Olink platform was selected for such an important study is a testament to its capabilities
— from SamanthaEvans at 01-14-2025 08:13
If you want to leave a comment, then you need Login or Register





Other news for TMO

TMOMarch 18, 2025Is Thermo Fisher Scientific Inc. TMO the Best Strong Buy Stock to Buy Right Now?  ~2 min.

Thermo Fisher Scientific Inc. (TMO) has been making waves in the market lately due to its impressive performance....

TMOMarch 16, 2025Thermo Fisher Scientific Welcomes New Senior VP and General Counsel  ~1 min.

Thermo Fisher Scientific Inc. (TMO) recently announced the appointment of Michael Boxer as its new Senior Vice President and General Counsel....

TMOMarch 14, 2025Market Whales and Their Recent Bets on TMO Options - Thermo Fisher Scientific NYSE:TMO - Benzinga  ~2 min.

Thermo Fisher Scientific Inc. (NYSE: TMO) has been attracting the attention of market whales with their recent bullish bets on TMO options....

TMOFebruary 27, 2025Thermo Fisher Scientific Expands Business with Acquisition of Solventum's Filtration Division for $4.1B  ~2 min.

Thermo Fisher Scientific, a leading global corporation specializing in scientific research and laboratory equipment, has made a significant move to expand its portfolio with the acquisition of Solventum's Filtration division. The deal, valued at $4.1 billion, will further enhance Thermo Fisher's position in the purification and filtration market. Solventum, a renowned player in the filtration indu...

TMOFebruary 26, 2025Solventum Announces Sale of its Purification Filtration Business to Thermo Fisher Scientific Inc. for 4.1B  ~2 min.

Solventum, a leading provider of purification filtration solutions, has announced the sale of its business to Thermo Fisher Scientific Inc. for a staggering amount of 4.1 billion dollars....



Related news

IBMFebruary 2, 2025IBM announces groundbreaking partnership with leading tech company  ~2 min.

International Business Machines Corporation (IBM), a global technology company, has recently announced a groundbreaking partnership with a leading tech company....

MDTNovember 17, 2024Medtronic MDT Announces Breakthrough in Medical Device Technology  ~2 min.

Medtronic Plc (NYSE:MDT) has made a groundbreaking advancement in medical device technology, leading to a surge in its stock value....

AZNFebruary 7, 2025AstraZeneca Plc Reports Strong Q4 2024 Earnings, Impressive Growth Prospects in the Pipeline  ~2 min.

AstraZeneca Plc, a renowned multinational pharmaceutical company, recently released its impressive Q4 2024 earnings report, showcasing remarkable growth prospects in its pipeline....

BIIBDecember 31, 2024Biogen Inc. BIIB: Revolutionizing Healthcare with Breakthrough Research  ~2 min.

Biogen Inc. (BIIB) has emerged as a standout player in the healthcare industry, continuously pushing the boundaries of medical research and development....

RTXJanuary 11, 2025RTX Corporation: A Trailblazer in Quantum Computing  ~2 min.

Quantum computing has emerged as one of the most promising technologies of the future, and RTX Corporation is leading the charge in this field....